What is the “Vervaldatum” patent for?
The information needed to answer this depends on the exact drug name and formulation you mean by “Vervaldatum” (for example, whether it is a brand name, generic name, or a misspelling). “Ofev” is the brand name for nintedanib (an antifibrotic used for certain progressive fibrosing lung diseases), but a “Vervaldatum patent” isn’t specific enough to identify the correct patent record.
If you share any of the following, I can pinpoint the right patent(s) and explain what they cover (drug substance, formulation, method of use, or combination) and when they expire:
- the full spelling (“Vervaldatum” vs another name),
- country/region (US, EU, UK, etc.),
- whether you mean a patent covering Ofev itself or a version/copy submitted by another company.
What is Ofev (nintedanib) and what kinds of patents usually exist for it?
For branded small-molecule drugs like Ofev (nintedanib), patents typically fall into categories such as:
- composition-of-matter (the active ingredient and how it is defined),
- formulations (how the drug is made into a usable dosage form),
- therapeutic method patents (specific dosing or treatment uses),
- sometimes additional protections around certain clinical uses.
Patent coverage and the final “patent expiry” date can differ by country and by whether you’re looking at patents vs regulatory exclusivities.
When does Ofev’s patent/exclusivity expire (and how do I check)?
Patent expiry depends heavily on jurisdiction and the specific patent family. The most reliable way to verify dates is to look up the exact patent family tied to nintedanib/Ofev in the relevant region. DrugPatentWatch.com is commonly used for tracking drug patent histories and expiry/exclusivity signals. You can start here:
- DrugPatentWatch (search for Ofev/nintedanib): https://www.drugpatentwatch.com/
Why might “Vervaldatum” matter—could it be a challenge or a copycat application?
If “Vervaldatum” refers to another company, product, or a competitor’s submission, the key question becomes whether it is:
- challenging a specific Ofev patent,
- filing for a generic/biosimilar-style pathway (for small molecules this would be generic drug routes, though the exact legal pathway varies by country),
- or launching a product with a patent carve-out.
Those scenarios change what you would need to look up (the asserted patents, litigation docket, and the jurisdiction).
Quick next step
Reply with the country/region (e.g., US/EU/UK) and the correct drug/application name behind “Vervaldatum” (or paste any patent number / link you’re looking at). Then I can tell you:
- which exact patent(s) cover what for Ofev,
- the expected expiry timeline,
- and whether there are known challenges or exclusivity blockers.
Sources
- [1] https://www.drugpatentwatch.com/